Athersys
Inc. (Nasdaq: ATHX) entered an exclusive partnership with Chugai
Pharmaceuticals to develop and commercialize MultiStem cell therapy for
ischemic stroke in Japan. The stock price climbed 42 cents to $3.01.
Athersys enters exclusive partnership
March 02, 2015 at 13:17 PM EST